Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats.
about
Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptorsAT2 Receptors: Potential Therapeutic Targets for Hypertension.The angiotensin II type 2 receptor and the kidney.The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressureAT2 receptors: beneficial counter-regulatory role in cardiovascular and renal functionAngiotensin II Type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFα production.Identification and characterization of a functional mitochondrial angiotensin system.NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats.Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling.The potential role of the angiotensin subtype 2 receptor in cardiovascular protection.Is reversal of endothelial dysfunction still an attractive target in modern cardiology?Addressing those two that go together: the angiotensin II receptors and their role in blood-flow regulation.Angiotensin II receptor blockers in the treatment of heart failure.Angiotensin AT2 receptors: cardiovascular hope or hype?Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxideDifferential regulation by AT(1) and AT(2) receptors of angiotensin II-stimulated cyclic GMP production in rat uterine artery and aorta.AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR.Renal angiotensin II receptors, hyperinsulinemia, and obesity.Reporter mouse strain provides a novel look at angiotensin type-2 receptor distribution in the central nervous systemVascular angiotensin II actions mediated by angiotensin II type 2 receptors.Influence of Angiotensin II Subtype 2 Receptor (AT(2)R) Antagonist, PD123319, on Cardiovascular Remodelling of Aged Spontaneously Hypertensive Rats during Chronic Angiotensin II Subtype 1 Receptor (AT(1)R) BlockadeAngiotensin II-nitric oxide interaction in glomerular arterioles.High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats.Pendrin protein abundance in the kidney is regulated by nitric oxide and cAMPInfluence of Fimasartan (a Novel AT(1) Receptor Blocker) on Catecholamine Release in the Adrenal Medulla of Spontaneously Hypertensive Rats.Antihypertensive agents and renal transplantation.Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.The frail renin-angiotensin system.Role of the angiotensin II receptor blocker valsartan in heart failure.Vascular smooth muscle cell motility: From migration to invasion.LOX-1 and angiotensin receptors, and their interplay.Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan.High aminopeptidase A activity contributes to blood pressure control in ob/ob mice by AT2 receptor-dependent mechanism.Cardiovascular and cerebrovascular outcomes in elderly hypertensive patients treated with either ARB or ACEI.High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive ratsValsartan-induced angioedema.Potentiation of the antihypertensive action of losartan by peripheral overexpression of the ANG II type 2 receptor.Response to letter regarding article, "AT2 receptor activation induces natriuresis and lowers blood pressure".Discordant responses to two classes of drugs acting on the renin-angiotensin system.Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT(2)- receptors.
P2860
Q28583017-DEA72D7A-2922-4194-97CF-9473DD90A47CQ30275852-7F9AC9FD-2696-434B-AE12-A3EB76D8D5C7Q30413945-5C6ED935-0698-435C-AE7B-40AD94ECB80EQ30414541-A91C3268-5936-4A69-84B1-145C0B2E7F33Q30415577-3AF3A2A2-39A6-4A15-85CF-E33281B22601Q30426697-19A0670B-DB20-48B9-913B-0E247A6C20BFQ30427934-BE46021E-7758-4EFE-BF3B-C9213594C36DQ30444178-D3067BBE-6DEE-46A6-8142-988B339E14F2Q30444722-C2796711-6236-4CBA-A340-28D425A06469Q30448757-6AD56ECE-C3BC-4430-A470-769818D6A376Q34179077-2605AECC-4BD3-4016-9C88-6EDA7EEBBFC5Q34238307-6DFD3058-B0B9-40F2-A0D4-B0F048CE8564Q34943387-B6C798F8-297A-4176-9F46-3D037E679BF8Q35045801-DDBD5636-9416-4633-895B-C07F1EDE819BQ35045808-8D611C17-91EC-4873-8DAA-921CFA6CCD17Q35046246-0418A1D0-AF6D-48FA-B46F-8766125F4064Q35047332-1339A71C-CBF9-4DCE-9E8E-5DBEADC0990CQ35574793-194838E4-F5FA-47B7-A814-7E037EBA94CAQ35656144-FCC92819-1A93-40EA-ADEF-ACB92C4FBCBCQ35686201-98487C5F-3EE4-4A73-84B5-3D817F234D52Q35830269-4EA6E89F-58F2-4459-9FD5-FC25494417A4Q36107865-8BB51462-3065-479A-ADEB-37C8AFDE5270Q36208883-0AFA12D8-CA73-4E3A-9745-83C35FD4926BQ36309486-1E2D9C98-28F9-41D8-BAB0-9B0535BE92A7Q36628809-7182F91A-DF79-48DE-8679-2F565E1D9BEDQ36765942-72CB3C8C-91D9-4458-A433-4A25F78A8DC1Q37097148-7EBF5039-8687-41CA-98E6-5114C053B362Q37150747-382F28A2-D51B-4AFB-B0EC-1F5B88414D86Q37739210-A43D6449-EE89-459F-B785-B55922452988Q37832151-D6C8B3A1-9E3F-488A-A55E-51762D7FF322Q37921158-832CAEE9-C022-470B-830F-11FCC9E2EA98Q38258427-B66A9656-F842-4ECB-83FA-1EF5554093AFQ38289835-6B0B0EAE-7A75-4DC0-96D4-4C9E192691CAQ41915019-D4F77E55-82C2-47CF-A3B8-125F260B7DC3Q41953838-5E37B9F0-5E58-4E51-9C6A-AF6D48471085Q42166125-91A9C7AE-1AA4-4FA4-B446-1724BCBDFFCAQ42503774-6D87817C-A032-4AD8-AF2E-9AF5E3D3EF04Q43108831-1F4BA03F-F9DD-45AF-99EE-AC82713A6F8BQ43907234-37FE7A3D-AE0B-47B8-8832-974F903BABA8Q43976707-09B3DE2D-9219-46E7-B98A-B021DFC3C3EF
P2860
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats.
@ast
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats.
@en
type
label
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats.
@ast
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats.
@en
prefLabel
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats.
@ast
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats.
@en
P2093
P356
P1433
P1476
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats.
@en
P2093
H M Siragy
M de Gasparo
P304
P356
10.1161/01.HYP.35.5.1074
P407
P577
2000-05-01T00:00:00Z